Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells
- 8 September 2015
- journal article
- research article
- Published by Springer Nature in Apoptosis
- Vol. 20 (11) , 1499-1507
Abstract
Epigenetic abnormalities are associated with non-small cell lung cancer (NSCLC) initiation and progression. Epigenetic drugs are being studied and in clinical trials. However, the molecular mechanism underlying the apoptosis by the epigenetic agents remains unclear. SUV39H1 is an important methyl-transferase for lysine 9 on histone H3 and usually related to gene transcriptional suppression, and chaetocin acts as the inhibitor of SUV39H1. We demonstrated here that chaetocin effectively suppressed the growth of multiple lung cancer cells through inducing apoptosis in a death receptor 5 (DR5)-dependent manner. Chaetocin treatment activated endoplasmic reticulum (ER) stress which gave rise to the up-regulation of ATF3 and CHOP. Furthermore, ATF3 and CHOP contributed to the induction of DR5 and subsequent apoptosis. When SUV39H1 was silenced with siRNA, the expression of ATF3, CHOP and DR5 was elevated. Thereafter, knockdown of SUV39H1 induced apoptosis in NSCLC cells. In summary, chaetocin pharmacologically inhibits the activity of SUV39H1 which provokes ER stress and results in up-regulation of ATF3 and CHOP, leading to DR5-dependent apoptosis eventually. These findings provide a novel interpretation on the anti-neoplastic activity of epigenetic drugs as a new therapeutic approach in NSCLC.Keywords
Funding Information
- National Natural Science Foundation of China (81472686, 31371402, 31171332)
This publication has 39 references indexed in Scilit:
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- Epigenetic Regulation of Surfactant Protein A Gene (SP-A) Expression in Fetal Lung Reveals a Critical Role for Suv39h Methyltransferases during Development and HypoxiaMolecular and Cellular Biology, 2011
- Immunohistochemical Detection of Activating Transcription Factor 3, a Hub of the Cellular Adaptive–Response Network2011
- Histone Deacetylase Inhibitors Downregulate Checkpoint Kinase 1 Expression to Induce Cell Death in Non-Small Cell Lung Cancer CellsPLOS ONE, 2010
- ERK/Ribosomal S6 Kinase (RSK) Signaling Positively Regulates Death Receptor 5 Expression through Co-activation of CHOP and Elk1Journal of Biological Chemistry, 2010
- ATF3 transcription factor and its emerging roles in immunity and cancerJournal of Molecular Medicine, 2009
- The Anticancer Agent Chaetocin Is a Competitive Substrate and Inhibitor of Thioredoxin ReductaseAntioxidants & Redox Signaling, 2009
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stressBlood, 2006
- Mediators of endoplasmic reticulum stress‐induced apoptosisEMBO Reports, 2006